Der Nephrologe

, Volume 6, Issue 2, pp 159–161

Belatacept nach Nierentransplantation unter Vermeidung von Steroiden

Für Sie gelesen
  • 77 Downloads

Belatacept after renal transplantation with avoidance of steroids

Literatur

  1. 1.
    Vincenti F, Charpentier B, Vanrenterghem Y et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10(3):535–546PubMedCrossRefGoogle Scholar
  2. 2.
    Durrbach A, Pestana JM, Pearson T et al (2010) A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 10(3):547–557PubMedCrossRefGoogle Scholar
  3. 3.
    Ekberg H, Tedesco-Silva H, Demirbas A et al (2007) Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357(25):2562–2575PubMedCrossRefGoogle Scholar
  4. 4.
    Buchler M, Caillard S, Barbier S et al (2007) Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant 7(11):2522–2531PubMedCrossRefGoogle Scholar
  5. 5.
    Citterio F (2001) Steroid side effects and their impact on transplantation outcome. Transplantation 72(12 Suppl):S75–S80PubMedGoogle Scholar
  6. 6.
    Matas AJ, Kandaswamy R, Gillingham KJ et al (2005) Prednisone-free maintenance immunosuppression: a 5-year experience. Am J Transplant 5(10):2473–2478PubMedCrossRefGoogle Scholar
  7. 7.
    Ferguson R, Grinyó J, Vincenti F et al (2011) Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant 11(1):66–76PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.III. Medizinische KlinikUniversitätsklinikum Hamburg-EppendorfHamburgDeutschland

Personalised recommendations